RE:RE:RE:RE:ONCY to make an "Oral Presentation" on Bracelet-1 at ASCO Amy Clark of U Penn is the Deputy director of clinical trials and an Assistant Prof in U penn medical school and hospitals.
Because of her pedigree, she wouldn't be standing up at ASCO to present the results of a failed trial. The exact opposite. Since her credibility is paramount, Dr. Amy Clark will be presenting on the success of the Bracelet-1 study and how pelareorep is able to induce an inflammatory response in metastatic breast cancer in advance of the addition of the PD-(L)1 immune checkpoint inhibitor (atezolizumab).
Roche should be very pleased with these results and I would expect them to make a move on ONCY very soon.